Why This Biotech Stock Was Bullish Enough To Relicense Its Own Drugs [Investor's Business Daily]
Reata Pharmaceuticals, Inc. - Class A (RETA)
Last reata pharmaceuticals, inc. - class a earnings: 2/19 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.reatapharma.com
Company Research
Source: Investors Business Daily
Related news 10/07/2019 A Relative Strength Rating upgrade for Reata Pharma shows improving technical performance. Will it continue? Here Are 3 Notable Pharma Stocks That Could Top Third-Quarter Estimates AbbVie Stock Is Poised To Become A Top 5 Pharma — But Should You Buy It? Biogen Stock Flailed On Alzheimer's Flop — Is This Biotech Stock A Buy Now? How This IBD Stock Of The Day Is Rattling Medical Giants Amgen, Mylan Reata Pharma Shows Rising Price Performance With Jump To 91 RS Rating Stocks Showing Rising Market Leadership: Reata Pharma Earns 82 RS Rating Millennials Are Losing Tons Of Money On Stocks Like Tesla Reata Pharma Shows Improved Relative Strength; Still Shy Of Benchmark Shares of Reata Pharmaceuticals ( RETA ) jumped Thursday after the biotech company reacquired the rights to several drugs from AbbVie ( ABBV ). The move shows confidence in two pivotal-stage drugs. Later this year, Reata expects to have the results of studies
Show less
Read more
Impact Snapshot
Event Time:
RETA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RETA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RETA alerts
High impacting Reata Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics